TRVITrevi Therapeutics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $12.48 (+4.65% today)

Market Cap: $1.53B

P/E (TTM): -40.60

Relative Strength (RS%): 98

-13.3% from 52-week high

CANSLIM: Passes criteria

Back to Scanner

TRVI

NASDAQCANSLIMRS 98Score 45

Trevi Therapeutics, Inc.

HealthcareBiotechnology$1.53B5 setups passing
$12.48
+4.6% ($0.55)
-13.3% from 52W High
P/E (TTM)
-40.60
Fwd P/E
PEG
Analyst Upside
EPS Growth
Gross Margin
0.0%
ROE
-25.5%
D/E
0.00
Div Yield
0.0%
Avg Volume
1.2M

Price Chart

Key Levels

SMA 200
$9.89
SMA 50
$11.24
Price
$12.48
52W High
$14.39

Setup Radar

5/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst